NEW YORK (GenomeWeb News) – Genetic Technologies announced today it is licensing patents related to its non-coding DNA technology to Conexio Genomics.

Financial and other terms of the non-exclusive deal were not disclosed.

Based in Fremantle, Western Australia, Conexio develop genetic sequencing and mutation detection products and provides services in those areas.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.